-
Free Space Continuous Variable Quantum Key Distribution with Discrete Phases
Authors:
Anju Rani,
Pooja Chandravanshi,
Jayanth Ramakrishnan,
Pravin Vaity,
P. Madhusudhan,
Tanya Sharma,
Pranav Bhardwaj,
Ayan Biswas,
R. P. Singh
Abstract:
Quantum Key Distribution (QKD) offers unconditional security in principle. Many QKD protocols have been proposed and demonstrated to ensure secure communication between two authenticated users. Continuous variable (CV) QKD offers many advantages over discrete variable (DV) QKD since it is cost-effective, compatible with current classical communication technologies, efficient even in daylight, and…
▽ More
Quantum Key Distribution (QKD) offers unconditional security in principle. Many QKD protocols have been proposed and demonstrated to ensure secure communication between two authenticated users. Continuous variable (CV) QKD offers many advantages over discrete variable (DV) QKD since it is cost-effective, compatible with current classical communication technologies, efficient even in daylight, and gives a higher secure key rate. Kee** this in view, we demonstrate a discrete modulated CVQKD protocol in the free space which is robust against polarization drift. We also present the simulation results with a noise model to account for the channel noise and the effects of various parameter changes on the secure key rate. These simulation results help us to verify the experimental values obtained for the implemented CVQKD.
△ Less
Submitted 22 May, 2023;
originally announced May 2023.
-
Minimizing Metastatic Risk in Radiotherapy Fractionation Schedules
Authors:
Hamidreza Badri,
Jagdish Ramakrishnan,
Kevin Leder
Abstract:
Metastasis is the process by which cells from a primary tumor disperse and form new tumors at distant anatomical locations. The treatment and prevention of metastatic cancer remains an extremely challenging problem. This work introduces a novel biologically motivated objective function to the radiation optimization community that takes into account metastatic risk instead of the status of the prim…
▽ More
Metastasis is the process by which cells from a primary tumor disperse and form new tumors at distant anatomical locations. The treatment and prevention of metastatic cancer remains an extremely challenging problem. This work introduces a novel biologically motivated objective function to the radiation optimization community that takes into account metastatic risk instead of the status of the primary tumor. In this work, we consider the problem of develo** fractionated irradiation schedules that minimize production of metastatic cancer cells while kee** normal tissue damage below an acceptable level. A dynamic programming framework is utilized to determine the optimal fractionation scheme. We evaluated our approach on a breast cancer case using the heart and the lung as organs-at-risk (OAR). For small tumor $α/β$ values, hypo-fractionated schedules were optimal, which is consistent with standard models. However, for relatively larger $α/β$ values, we found the type of schedule depended on various parameters such as the time when metastatic risk was evaluated, the $α/β$ values of the OARs, and the normal tissue sparing factors. Interestingly, in contrast to standard models, hypo-fractionated and semi-hypo-fractionated schedules (large initial doses with doses tapering off with time) were suggested even with large tumor $α$/$β$ values. Numerical results indicate potential for significant reduction in metastatic risk.
△ Less
Submitted 17 November, 2015; v1 submitted 27 December, 2013;
originally announced December 2013.
-
Optimization of Radiation Therapy Fractionation Schedules in the Presence of Tumor Repopulation
Authors:
Thomas Bortfeld,
Jagdish Ramakrishnan,
John N. Tsitsiklis,
Jan Unkelbach
Abstract:
We analyze the effect of tumor repopulation on optimal dose delivery in radiation therapy. We are primarily motivated by accelerated tumor repopulation towards the end of radiation treatment, which is believed to play a role in treatment failure for some tumor sites. A dynamic programming framework is developed to determine an optimal fractionation scheme based on a model of cell kill due to radia…
▽ More
We analyze the effect of tumor repopulation on optimal dose delivery in radiation therapy. We are primarily motivated by accelerated tumor repopulation towards the end of radiation treatment, which is believed to play a role in treatment failure for some tumor sites. A dynamic programming framework is developed to determine an optimal fractionation scheme based on a model of cell kill due to radiation and tumor growth in between treatment days. We find that faster tumor growth suggests shorter overall treatment duration. In addition, the presence of accelerated repopulation suggests larger dose fractions later in the treatment to compensate for the increased tumor proliferation. We prove that the optimal dose fractions are increasing over time. Numerical simulations indicate potential for improvement in treatment effectiveness.
△ Less
Submitted 24 April, 2015; v1 submitted 4 December, 2013;
originally announced December 2013.
-
Exploiting tumor shrinkage through temporal optimization of radiotherapy
Authors:
Jan Unkelbach,
David Craft,
Theodore Hong,
David Papp,
Jagdish Ramakrishnan,
Ehsan Salari,
John Wolfgang,
Thomas Bortfeld
Abstract:
In multi-stage radiotherapy, a patient is treated in several stages separated by weeks or months. This regimen has been motivated mostly by radiobiological considerations, but also provides an approach to reduce normal tissue dose by exploiting tumor shrinkage. The paper considers the optimal design of multi-stage treatments, motivated by the clinical management of large liver tumors for which nor…
▽ More
In multi-stage radiotherapy, a patient is treated in several stages separated by weeks or months. This regimen has been motivated mostly by radiobiological considerations, but also provides an approach to reduce normal tissue dose by exploiting tumor shrinkage. The paper considers the optimal design of multi-stage treatments, motivated by the clinical management of large liver tumors for which normal liver dose constraints prohibit the administration of an ablative radiation dose in a single treatment.
We introduce a dynamic tumor model that incorporates three factors: radiation induced cell kill, tumor shrinkage, and tumor cell repopulation. The design of multi-stage radiotherapy is formulated as a mathematical optimization problem in which the total dose to the liver is minimized, subject to delivering the prescribed dose to the tumor. Based on the model, we gain insight into the optimal administration of radiation over time, i.e. the optimal treatment gaps and dose levels.
We analyze treatments consisting of two stages in detail. The analysis confirms the intuition that the second stage should be delivered just before the tumor size reaches a minimum and repopulation overcompensates shrinking. Furthermore, it was found that, for a large range of model parameters, approximately one third of the dose should be delivered in the first stage. The projected benefit of multi-stage treatments depends on model assumptions. However, the model predicts large liver dose reductions by more than a factor of two for plausible model parameters.
The analysis of the tumor model suggests that substantial reduction in normal tissue dose can be achieved by exploiting tumor shrinkage via an optimal design of multi-stage treatments. This suggests taking a fresh look at multi-stage radiotherapy for selected disease sites where substantial tumor regression translates into reduced target volumes.
△ Less
Submitted 9 May, 2014; v1 submitted 22 November, 2013;
originally announced November 2013.
-
A Dynamic Programming Approach to Adaptive Fractionation
Authors:
Jagdish Ramakrishnan,
David Craft,
Thomas Bortfeld,
John N. Tsitsiklis
Abstract:
We conduct a theoretical study of various solution methods for the adaptive fractionation problem. The two messages of this paper are: (i) dynamic programming (DP) is a useful framework for adaptive radiation therapy, particularly adaptive fractionation, because it allows us to assess how close to optimal different methods are, and (ii) heuristic methods proposed in this paper are near-optimal, an…
▽ More
We conduct a theoretical study of various solution methods for the adaptive fractionation problem. The two messages of this paper are: (i) dynamic programming (DP) is a useful framework for adaptive radiation therapy, particularly adaptive fractionation, because it allows us to assess how close to optimal different methods are, and (ii) heuristic methods proposed in this paper are near-optimal, and therefore, can be used to evaluate the best possible benefit of using an adaptive fraction size.
The essence of adaptive fractionation is to increase the fraction size when the tumor and organ-at-risk (OAR) are far apart (a "favorable" anatomy) and to decrease the fraction size when they are close together. Given that a fixed prescribed dose must be delivered to the tumor over the course of the treatment, such an approach results in a lower cumulative dose to the OAR when compared to that resulting from standard fractionation. We first establish a benchmark by using the DP algorithm to solve the problem exactly. In this case, we characterize the structure of an optimal policy, which provides guidance for our choice of heuristics. We develop two intuitive, numerically near-optimal heuristic policies, which could be used for more complex, high-dimensional problems. Furthermore, one of the heuristics requires only a statistic of the motion probability distribution, making it a reasonable method for use in a realistic setting. Numerically, we find that the amount of decrease in dose to the OAR can vary significantly (5 - 85%) depending on the amount of motion in the anatomy, the number of fractions, and the range of fraction sizes allowed. In general, the decrease in dose to the OAR is more pronounced when: (i) we have a high probability of large tumor-OAR distances, (ii) we use many fractions (as in a hyper-fractionated setting), and (iii) we allow large daily fraction size deviations.
△ Less
Submitted 4 December, 2011; v1 submitted 21 September, 2011;
originally announced September 2011.
